Yellow Onion. Product is labeled in part: "***FC Mix Stir Fry "D"***Refrigerate at 34 F***" Item # 301280 FC MIX STIR FRY "D" 4/5...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1920-2012.
FreshPoint South Florida is recalling sliced fresh yellow onions and salsa products processed using yellow onions sourced from Gills Onions, LLC which were recalled for Listeria monocytogenes.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1920-2012.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Freshpoint South Florida or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1920-2012.
FreshPoint South Florida
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Freshpoint South Florida Recall FAQ
Freshpoint South Florida is the subject of a produce safety report: Yellow Onion. Product is labeled in part: "***FC Mix Stir Fry "D"***Refrigerate at 34 F***" Item # 301280 FC MIX STIR FRY "D" 4/5.... The notice was published on July 27, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 7 units are potentially affected.